Glotur Invest

Glotur Invest

Glotur Invest emerged following the 2015 acquisition of Grupo Casa Saba by Carlos Slim's Grupo Carso, a transaction that crystallized significant liquidity for the Argüelles family. Casa Saba had been Mexico's largest pharmaceutical distributor, founded by Enrique Argüelles and later expanded into a publicly traded enterprise before Slim's takeover. The office now stewards that capital with a mandate centered on principal investments rather than passive fund allocations. The deployment strategy concentrates on direct equity and real asset opportunities, primarily in Mexico and Spain. In real estate, the office has partnered with Slim's Inmobiliaria Carso on mixed-use developments in Mexico City, leveraging the relationship that began with the Casa Saba sale. On the private equity side, Glotur targets control acquisitions of mid-market industrial and manufacturing companies in Southern Europe, with a focus on firms possessing export capacity to Latin American markets. The office does not operate as an open fund and does not syndicate deals to external limited partners. The team operates from a single location, maintaining a lean structure typical of a family office that co-invests alongside operating partners rather than building internal deal-execution capacity. The family's philanthropic activities are conducted through a separate structure, and no adjacent club memberships or multi-family vehicles have been disclosed. In 2019, the office acquired a controlling stake in a Spanish industrial-component manufacturer, reflecting the cross-Atlantic mandate that defines its post-liquidity deployment phase. Glotur's architecture differs from most single-family offices formed after a liquidity event: rather than diversifying across third-party funds, the family uses the Slim relationship as a co-investment anchor for domestic real estate while pursuing independent control deals in Europe. This dual-track approach—anchored partnerships in one geography, proprietary control acquisitions in another—creates a portfolio with concentrated downside protection and asymmetric upside on operating-company bets.